Evidence Library
Filter by drug, type, year, and open access.
Showing 1–3 of 3 results
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults — Canadian Journal of Psychiatry (2024)• Drug: amoxapineDOIPMID
- APA Clinical Practice Guideline for the Treatment of Depression — American Psychiatric Association (2023)• Drug: amoxapineOpen access
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: amoxapineOpen access
